General MedicationsORALStandard
METHSCOPOLAMINE BROMIDE
METHSCOPOLAMINE BROMIDE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview METHSCOPOLAMINE BROMIDE is listed in Drugs@FDA under application 216786 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient METHSCOPOLAMINE BROMIDE Form and strength TABLET;ORAL - 5MG Sponsor NE RX PHARMA Submission history Latest submission status date: 2024-02-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHSCOPOLAMINE BROMIDE is listed in Drugs@FDA under application 216786 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHSCOPOLAMINE BROMIDE Form and strength TABLET;ORAL - 5MG Sponsor NE RX PHARMA Submission history Latest submission status date: 2024-02-01 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.